{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:30:05Z","timestamp":1794583805133,"version":"4.9.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory biomarker that is used to predict mortality, readmission, early discharge, and LOS, thus, serves as a useful tool for ED physicians. Our study aims to analyze the efficacy of suPAR in predicting these prognostic markers in ED.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We performed a comprehensive search on 6 databases from the inception to 30th November 2022, to select the following eligibility criteria; a) observation or triage trial studies investigating the role of suPAR levels in predicting: 30 day and 90-day mortality, 30-day readmission, early discharge (within 24hr), and LOS in patients coming to AMU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 13 studies were included, with a population size of 35,178, of which 52.9% were female with a mean age of 62.93 years. Increased risk of 30-day mortality (RR = 10.52; 95% CI = 4.82\u201322.95; I2 = 38%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .00001), and risk of 90-day mortality (RR = 5.76; 95% CI = 3.35\u20139.91; I2 = 36%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .00001) was observed in high suPAR patients. However, a slightly increased risk was observed for 30-day readmission (RR = 1.50; 95% CI = 1.16\u20131.94; I2 = 54%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .002). More people were discharged within 24hr in the low suPAR level group compared to high suPAR group (RR = 0.46; 95% CI = 0.40\u20130.53; I2 = 41%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .00001). LOS was thrice as long in high suPAR level patients than in patients with low suPAR (WMD = 3.20; 95% CI = 1.84\u20134.56; I2 = 99%;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .00001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>suPAR is proven to be a significant marker in predicting 30-day and 90-day mortality in ED patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000035718","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:00:32Z","timestamp":1699624832000},"page":"e35718","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis"],"prefix":"10.1097","volume":"102","author":[{"given":"Syeda Tayyaba","family":"Rehan","sequence":"first","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan ul","family":"Hussain","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Ali","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal Ashok","family":"Kumar","sequence":"additional","affiliation":[{"name":"Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehroze","family":"Tabassum","sequence":"additional","affiliation":[{"name":"King Edward Medical College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hasanain","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Aga Khan University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Aga Khan University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gibran","family":"Ali","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Mayo Clinic - Rochester, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohaib","family":"Yousaf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tower Health - Reading Hospital, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6705-2030","authenticated-orcid":false,"given":"Muhammad Sohaib","family":"Asghar","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic - Rochester, NY, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e94649","DOI":"10.1371\/journal.pone.0094649","article-title":"Prognosis and risk factors for deterioration in patients admitted to a medical emergency department.","volume":"9","author":"Henriksen","year":"2014","journal-title":"PLoS One"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1757-7241-19-42","article-title":"Emergency department triage scales and their components: a systematic review of the scientific evidence.","volume":"19","author":"Farrohknia","year":"2011","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/emermed-2016-206295","article-title":"Five-level emergency triage systems: variation in assessment of validity.","volume":"34","author":"Kuriyama","year":"2017","journal-title":"Emerg Med J"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s13054-015-1098-z","article-title":"Biomarkers from distinct biological pathways improve early risk stratification in medical emergency patients: the multinational, prospective, observational TRIAGE study.","volume":"19","author":"Schuetz","year":"2015","journal-title":"Crit Care"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1741-7015-12-80","article-title":"Risk stratification in emergency patients by copeptin.","volume":"12","author":"Iversen","year":"2014","journal-title":"BMC Med"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease.","volume":"373","author":"Hayek","year":"2015","journal-title":"N Engl J Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jchf.2016.12.008","article-title":"Soluble urokinase-type plasminogen activator receptor improves risk prediction in patients with chronic heart failure.","volume":"5","author":"Koller","year":"2017","journal-title":"JACC Heart Fail"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1911481","article-title":"Soluble urokinase receptor and acute kidney injury.","volume":"382","author":"Hayek","year":"2020","journal-title":"N Engl J Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball.","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis Markers"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-018-0141-8","article-title":"Healthy lifestyles reduce suPAR and mortality in a Danish general population study.","volume":"16","author":"Haupt","year":"2019","journal-title":"Immun Ageing"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s40121-020-00301-w","article-title":"Prognostic role of soluble urokinase plasminogen activator receptor at the emergency department: a position paper by the hellenic sepsis study group.","volume":"9","author":"Velissaris","year":"2020","journal-title":"Infect Dis Ther"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/emermed-2015-205444","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality A retrospective cohort study.","volume":"33","author":"Rasmussen","year":"2016","journal-title":"Emerg Med J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/cc11434","article-title":"Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study.","volume":"16","author":"Haupt","year":"2012","journal-title":"Crit Care"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jemermed.2015.04.015","article-title":"suPAR \u2013 A future prognostic biomarker in emergency medicine.","volume":"48","author":"\u00d8stervig","year":"2015","journal-title":"J Emerg Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/CCM.0000000000003441","article-title":"Combining national early warning score with soluble urokinase plasminogen activator receptor (suPAR) improves risk prediction in acute medical patients: a registry-based cohort study.","volume":"46","author":"Rasmussen","year":"2018","journal-title":"Crit Care Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.4103\/jfmpc.jfmpc_116_19","article-title":"Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department.","volume":"8","author":"Kumar","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"3403549","DOI":"10.1155\/2019\/3403549","article-title":"Early discharge from the emergency department based on soluble urokinase plasminogen activator receptor (suPAR) levels: a TRIAGE III substudy.","volume":"2019","author":"Schultz","year":"2019","journal-title":"Dis Markers"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.3390\/jcm11123283","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) in the Emergency Department (Ed): a tool for the assessment of elderly patients.","volume":"11","author":"Holstein","year":"2022","journal-title":"J Clin Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nutres.2017.04.006","article-title":"A high-protein diet during hospitalization is associated with an accelerated decrease in soluble urokinase plasminogen activator receptor levels in acutely ill elderly medical patients with SIRS.","volume":"41","author":"Tavenier","year":"2017","journal-title":"Nutr Res (New York, N.Y.)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"117727192110346","DOI":"10.1177\/11772719211034685","article-title":"suPAR Cut-Offs for risk stratification in patients with symptoms of COVID-19.","volume":"16","author":"Altintas","year":"2021","journal-title":"Biomarker Insights"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A re-evaluation of random-effects meta-analysis.","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2796.2012.02569.x","article-title":"Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.","volume":"272","author":"Uusitalo-Sepp\u00e4l\u00e4","year":"2012","journal-title":"J Intern Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13049-021-00908-z","article-title":"Soluble urokinase plasminogen activator receptor and lactate as prognostic biomarkers in patients presenting with non-specific chief complaints in the pre-hospital setting \u2013 the PRIUS-study.","volume":"29","author":"Ivic","year":"2021","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jemermed.2021.03.012","article-title":"Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department.","volume":"61","author":"Stauning","year":"2021","journal-title":"J Emerg Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/bcp.14982","article-title":"Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department.","volume":"88","author":"Bengaard","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12873-021-00544-x","article-title":"suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department.","volume":"21","author":"Santeri","year":"2021","journal-title":"BMC Emerg Med"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"11772719221081789","DOI":"10.1177\/11772719221081789","article-title":"Utilization of prognostic biomarker soluble urokinase plasminogen activator receptor in the emergency department: a tool for safe and more efficient decision-making.","volume":"17","author":"Holstein","year":"2022","journal-title":"Biomarker Insights"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13613-020-00729-w","article-title":"TRIAGE study group Prognostic performance of endothelial biomarkers to early predict clinical deterioration of patients with suspected bacterial infection and sepsis admitted to the emergency department.","volume":"10","author":"Lafon","year":"2020","journal-title":"Ann Intensive Care"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12931-019-1234-4","article-title":"The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma - a retrospective cohort study.","volume":"20","author":"H\u00e5kansson","year":"2019","journal-title":"Respir Res"},{"key":"R35-20250504","first-page":"A5146","article-title":"suPAR as a biomarker for risk of readmission and mortality in the acute medical setting.","volume":"62","author":"Nayak","year":"2015","journal-title":"Dan Med J"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2021.02.009","article-title":"Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.","volume":"92","author":"Chenevier-Gobeaux","year":"2021","journal-title":"Clin Biochem"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.4049\/jimmunol.168.7.3507","article-title":"Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.","volume":"168","author":"Rijneveld","year":"2002","journal-title":"J Immunol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/00365540310017366","article-title":"Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome.","volume":"36","author":"\u00d8stergaard","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","article-title":"Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.","volume":"96","author":"Sidenius","year":"2000","journal-title":"Blood"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2011.02363.x","article-title":"Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study.","volume":"270","author":"Huttunen","year":"2011","journal-title":"J Intern Med"},{"key":"R42-20250504","first-page":"686","article-title":"The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.","volume":"6","author":"Eugen-Olsen","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0196-0644(05)81698-1","article-title":"\u201cBounces\u201d: an analysis of short-term return visits to a public hospital emergency department.","volume":"19","author":"Pierce","year":"1990","journal-title":"Ann Emerg Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/jama.2016.0649","article-title":"In-Hospital outcomes and costs among patients hospitalized during a return visit to the emergency department.","volume":"315","author":"Sabbatini","year":"2016","journal-title":"JAMA"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-1497.2005.00291.x","article-title":"Mortality prediction with a single general self-rated health question A meta-analysis.","volume":"21","author":"DeSalvo","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"19761","DOI":"10.1038\/s41598-022-24422-z","article-title":"Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population.","volume":"12","author":"Tavenier","year":"2022","journal-title":"Sci Rep"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13049-020-00743-8","article-title":"Self-rated worry is associated with hospital admission in out-of-hours telephone triage - a prospective cohort study.","volume":"28","author":"Gamst-Jensen","year":"2020","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ajem.2018.05.012","article-title":"Septic acute kidney injury patients in the emergency department: the risk factors and its correlation to serum lactate.","volume":"37","author":"Hsu","year":"2019","journal-title":"Am J Emerg Med"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"e0209","DOI":"10.1097\/MD.0000000000010209","article-title":"Difference between elderly and non-elderly patients in using serum lactate level to predict mortality caused by sepsis in the emergency department.","volume":"97","author":"Cheng","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"e0190519","DOI":"10.1371\/journal.pone.0190519","article-title":"Serum lactate upon emergency department arrival as a predictor of 30-day in-hospital mortality in an unselected population.","volume":"13","author":"Park","year":"2018","journal-title":"PLoS One"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cca.2018.03.022","article-title":"C-reactive protein and emergency department seven days revisit.","volume":"481","author":"Ziv-Baran","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"010702","DOI":"10.11613\/BM.2019.010702","article-title":"Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department.","volume":"29","author":"Garc\u00eda de Guadiana-Romualdo","year":"2019","journal-title":"Biochem Med (Zagreb)"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13049-021-00964-5","article-title":"Pre-hospital suPAR, lactate and CRP measurements for decision-making: a prospective, observational study of patients presenting non-specific complaints.","volume":"29","author":"Jousi","year":"2021","journal-title":"Scand J Trauma Resusc Emerg Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T22:29:13Z","timestamp":1746311353000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":49,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035718","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]}}}